AMRZ - CIK 0002035989
The table below shows Amrize Ltd's income statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Revenue | $11.81B | $11.70B | $11.68B |
| Cost of revenue | $8.78B | $8.63B | $8.91B |
| Gross profit | $3.03B | $3.07B | $2.77B |
| R&D | - | - | - |
| SG&A | $1.13B | $944.00M | $898.00M |
| Operating income | $1.91B | $2.19B | $1.89B |
| Income tax | $326.00M | $368.00M | $361.00M |
| Net income | $1.19B |
Amrize Ltd reported annual revenue of $11.81B for fiscal year 2025. That is up 0.9% from $11.70B in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.27B |
| $956.00M |
| EPS (diluted) | $2.14 | $2.30 | $1.73 |